We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Glucose-Guzzling Immune Cells May Drive Coronary Artery Disease

News   Mar 16, 2016

 
Glucose-Guzzling Immune Cells May Drive Coronary Artery Disease
 
 
Advertisement
 

RELATED ARTICLES

First Comprehensive Review of COVID-19's Effects Outside the Lung Published

News

The first extensive review of COVID-19's effects on all affected organs outside the lungs has been published in Nature Medicine, by researchers from Columbia University.

READ MORE

SARS-CoV-2 Immunity Rapidly Declines Within Months of Infection

News

A recent preprint study indicates that there is a rapid decline in the levels of SARS-CoV-2 neutralizing antibodies during the weeks following initial infection. This raises questions over the potential for re-infection, the effectiveness that may be expected from vaccination and the viable window for antibody testing in disease surveillance.

READ MORE

Why Lopinavir and Hydroxychloroquine Are Ineffective in COVID-19 Patients

News

A research group has discovered that the concentration of lopinavir and hydroxychloroquine in the lungs of COVID-19 patients is not sufficient to fight the virus.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE